SLDB logo

Solid Biosciences (SLDB)

Profile

Full Name

Solid Biosciences Inc.

Ticker Symbol

SLDB

Exchange

NASDAQ

Country

United States

IPO

January 26, 2018

Indexes

Not included

Employees

100

Key Details

Price

$2.52(-6.67%)

Market cap

$195.28M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

-

Annual EPS

-$3.06(+36.65% YoY)

PE ratio

-

Next earnings date

May 15, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price Performance

Price Range

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Shares Outstanding

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

EPS

Profit

Expenses

EBIT & EBITDA

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Liabilities

Debt

Equity & Capital

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

CAPEX

Free Cash Flow

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

ROA & ROE

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Analyst ratings

Recent major analysts updates

Mar 13, 25 JP Morgan
Overweight
Mar 10, 25 HC Wainwright & Co.
Buy
Mar 7, 25 Citizens Capital Markets
Market Outperform
Mar 7, 25 Chardan Capital
Buy
Feb 19, 25 Chardan Capital
Buy
Jan 13, 25 HC Wainwright & Co.
Buy
Jan 10, 25 HC Wainwright & Co.
Buy
Jan 8, 25 Truist Securities
Buy
Dec 13, 24 Wedbush
Outperform
Dec 12, 24 HC Wainwright& Co.
Buy

Institutional Ownership

  • What is the ticker symbol for Solid Biosciences?
  • Does Solid Biosciences pay dividends?
  • What sector is Solid Biosciences in?
  • What industry is Solid Biosciences in?
  • What country is Solid Biosciences based in?
  • When did Solid Biosciences go public?
  • Is Solid Biosciences in the S&P 500?
  • Is Solid Biosciences in the NASDAQ 100?
  • Is Solid Biosciences in the Dow Jones?
  • When was Solid Biosciences's last earnings report?
  • When does Solid Biosciences report earnings?
  • Should I buy Solid Biosciences stock now?

What is the ticker symbol for Solid Biosciences?

The ticker symbol for Solid Biosciences is NASDAQ:SLDB

Does Solid Biosciences pay dividends?

No, Solid Biosciences does not pay dividends

What sector is Solid Biosciences in?

Solid Biosciences is in the Healthcare sector

What industry is Solid Biosciences in?

Solid Biosciences is in the Biotechnology industry

What country is Solid Biosciences based in?

Solid Biosciences is headquartered in United States

When did Solid Biosciences go public?

Solid Biosciences's initial public offering (IPO) was on January 26, 2018

Is Solid Biosciences in the S&P 500?

No, Solid Biosciences is not included in the S&P 500 index

Is Solid Biosciences in the NASDAQ 100?

No, Solid Biosciences is not included in the NASDAQ 100 index

Is Solid Biosciences in the Dow Jones?

No, Solid Biosciences is not included in the Dow Jones index

When was Solid Biosciences's last earnings report?

Solid Biosciences's most recent earnings report was on Mar 6, 2025

When does Solid Biosciences report earnings?

The next expected earnings date for Solid Biosciences is May 15, 2025

Should I buy Solid Biosciences stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page